Robert Shalwitz - Net Worth and Insider Trading

Robert Shalwitz Net Worth

The estimated net worth of Robert Shalwitz is at least $417,061 dollars as of 2024-11-13. Robert Shalwitz is the Chief Medical Officer of Akebia Therapeutics Inc and owns about 214,980 shares of Akebia Therapeutics Inc (AKBA) stock worth over $417,061. Details can be seen in Robert Shalwitz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Shalwitz has not made any transactions after 2014-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Shalwitz

To

Robert Shalwitz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Shalwitz owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .

Click here to see the complete history of Robert Shalwitz’s form 4 insider trades.

Insider Ownership Summary of Robert Shalwitz

Ticker Comapny Transaction Date Type of Owner
AKBA Akebia Therapeutics Inc 2014-03-19 Chief Medical Officer

Robert Shalwitz Latest Holdings Summary

Robert Shalwitz currently owns a total of 1 stock. Robert Shalwitz owns 214,980 shares of Akebia Therapeutics Inc (AKBA) as of March 19, 2014, with a value of $417,061.

Latest Holdings of Robert Shalwitz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKBA Akebia Therapeutics Inc 2014-03-19 214,980 1.94 417,061

Holding Weightings of Robert Shalwitz


Robert Shalwitz Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Shalwitz has made a total of 0 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years. The most-recent trade in Akebia Therapeutics Inc is the sale of 0 shares on March 19, 2014, which brought Robert Shalwitz around $0.

Insider Trading History of Robert Shalwitz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Shalwitz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Shalwitz Ownership Network

Ownership Network List of Robert Shalwitz

No Data

Ownership Network Relation of Robert Shalwitz

Insider Network Chart

Robert Shalwitz Owned Company Details

What does Akebia Therapeutics Inc do?

Who are the key executives at Akebia Therapeutics Inc?

Robert Shalwitz is the Chief Medical Officer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & General Counsel & Sec. Nicole R. Hadas , and SVP & Chief Medical Officer Steven Keith Burke .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, Robert Shalwitz made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 88,587 shares made by Nicole R. Hadas .

In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akebia Therapeutics Inc Insider Transactions

No Available Data

Robert Shalwitz Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Shalwitz. You might contact Robert Shalwitz via mailing address: 2549 Bryden Rd, Bexley Oh 43209.